Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy

Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy

Item
http://www.wikidata.org/entity/Q28278406
AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Vacuum-Sealing as a Treatment Option for Severe Anthracycline Extravasation in a Breast Cancer Patient.Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovaryDexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in PigsAnthracycline extravasation injuries: management with dexrazoxane.Management of anthracycline extravasation into the pleural spaceAll-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathwayDexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.Treatment of anthracycline extravasations using dexrazoxane.Dexrazoxane: a management option for anthracycline extravasations.Extravasation injuries: a review.Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia.Anthraquinones As Pharmacological Tools and Drugs.Diethyl Blechnic, a Novel Natural Product Isolated from Bunge, Inhibits Doxorubicin-Induced Apoptosis by Inhibiting ROS and Activating JNK1/2
P2860

Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy

Item
http://www.wikidata.org/entity/Q28278406
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@ast
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@en
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@nl
type
label
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@ast
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@en
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@nl
prefLabel
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@ast
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@en
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P577
P5875
P698
P921
P3181
P356
P1433
P1476
Dexrazoxane (Totect): FDA revi ...... ous anthracycline chemotherapy
@en
P2093
P304
P31
P3181
P356
10.1634/THEONCOLOGIST.2007-0247
P407
P433
P478
P577
P5875
P698
P921